Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10533864 | 0.94 | AGTR1 (0.49) | AGTR1AGTR2 | |
| SCHEMBL287 | 0.90 | AGTR1 (0.51) | AGTR1AGTR2 | |
| SCHEMBL7171699 | 0.88 | AGTR1 (0.57) | AGTR1AGTR2 | |
| SCHEMBL459 | 0.85 | AGTR1 (0.52) | AGTR1AGTR2 | |
| SCHEMBL317 | 0.84 | AGTR1 (0.55) | AGTR1AGTR2 | |
| SCHEMBL9328849 | 0.84 | AGTR1 (0.64) | AGTR1AGTR2 | |
| SCHEMBL9558411 | 0.83 | AGTR1 (0.47) | AGTR1AGTR2 | |
| SCHEMBL7175115 | 0.82 | AGTR2 (0.49) | AGTR1AGTR2 | |
| SCHEMBL7366694 | 0.82 | AGTR1 (0.56) | AGTR1AGTR2 | |
| SCHEMBL9207303 | 0.82 | AGTR1 (0.46) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0754042-A4 | TREATMENT OF ATHEROSCLEROSIS WITH ANGIOTENSIN II RECEPTOR BLOCKING IMIDAZOLES | MERCK & CO INC (US) | 2004-06-23 | — | — | EP | disclosed |
| EP-0754042-A1 | TREATMENT OF ATHEROSCLEROSIS WITH ANGIOTENSIN II RECEPTOR BLOCKING IMIDAZOLES | MERCK & CO. INC. (US) | 1997-01-22 | — | — | EP | disclosed |
| WO-1995026188-A1 | TREATMENT OF ATHEROSCLEROSIS WITH ANGIOTENSIN II RECEPTOR BLOCKING IMIDAZOLES | MERCK & CO., INC. (US) | 1995-10-05 | — | — | WO | disclosed |